The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials

INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease, but no drug therapies have been approved to date. While glucagon-like peptide-1 (GLP-1) analogues may help in the management, the existing evidence remains conflicting. AIM: This meta-analysis aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Adnan, Amjad, Waseem, Inayat, Faisal, Nadeem, Mahum, Weissman, Simcha, Malik, Muhammad Imran, Jajja, Ans Ahmad, Khan, Ahmad, Tabibian, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050979/
https://www.ncbi.nlm.nih.gov/pubmed/37007754
http://dx.doi.org/10.5114/pg.2022.112775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050979/
https://www.ncbi.nlm.nih.gov/pubmed/37007754
http://dx.doi.org/10.5114/pg.2022.112775

Ejemplares similares